Camlin Fine Sciences
CAMLINFINE · Chemicals > Chemicals · Chairman: Ashish Dandekar · MD: Ashish Dandekar · Listing date: Jan. 20, 2015 · Employees: 430 · Mumbai · http://www.camlinfs.com

Stock Price vs Company Growth
1d
3.4%
1w
8.5%
1m
23.0%
3m
27.4%
6m
48.5%
1y
36.9%
5y
4.4%
10y
1.9%
all
2.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 109 3.4%
108
192
Company Overview

Sales
1,778 Cr
Growth: 8.4%
Profit after Tax
-61.3 Cr
Growth: 109.9%
Small Cap
2,085 Cr
P/S: 1.2x
Industry P/S: 1.3x
Fundamentals

Sales (Cr) ₹ 1,778
Growth 8.4%
EBITDA 7.5%
P/S 1.2x
Dividend 0.0%
P/E -136.4x
Book Value ₹ 43.8
PEG Ratio -16.7x
ROE -7.0%
P/B 2.6x
Shareholding Pattern

Institutions
Icici Prudential Midcap Fund
8.62 %
Sbi Flexicap Fund
7.93 %
Infinity Direct Holding
4.82 %
Nirmal Vinod Momaya
2.82 %
Kuwait Investment Authority Fund 225
1.99 %
Promoters
Ashish Subhash Dandekar
11.02 %
Camart Industries Ltd
4.17 %
Vibha Agencies Pvt Ltd
2.04 %
Anagha Subhash Dandekar
1.19 %
Cafco Consultants Limited
1.17 %
Others
Increase    Decrease    No change
Company Profile Detailed

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.
Investors (97)
Followers (7)